Raumedic is working on an energy plant project at its Helmbrechts, Germany headquarters to generate heat and power from renewable sources.
The medical device component developer and manufacturer expects to cut its carbon dioxide emissions by 85% through the collaboration with energy network operator E.ON.
It’s the latest sustainability move in the medtech supply chain, as medical device OEMs, contract manufacturers and suppliers work to reduce emissions of greenhouse gases that contribute to global warming.
A new wood chip heating plant will supply the entire Raumedic campus with heat, replacing natural gas combustion with biomass. Raumedic says the biomass will save around 1,800 tons of carbon dioxide emissions annually while offering long-term price stability.
The facility is scheduled to go online in the fourth quarter of 2024 after construction and a test phase.
“The Energy Center project is an important part of our energy concept at Raumedic,” Raumedic Sustainability Manager and Energy Center Project Manager Maximilian Hofmann said in a news release. “The construction of our own wood chip heating plant represents the best solution in terms of sustainability and cost-effectiveness. The project is our foundation on the way to climate neutrality.”
Raumedic is also installing 2,000 photovoltaic panels on the roof of a production building. Those solar panels are expected to generate around 880,000 kWh of electricity per year, or the equivalent of 220 households of four.
“The energy transition is in full swing in all industrial sectors,” Raumedic CEO Stefan Seuferling said in the news release. “The medical technology and pharmaceutical industries need sustainable supply chains in order to be able to bring sustainable products to the market themselves. Raumedic is showing itself to be a competent and future-proof partner for the entire industry with an innovative and environmentally friendly energy concept.”
Raumedic has more than 1,200 employees worldwide and recently expanded its U.S. headquarters in Mills River, North Carolina. The company makes plastic-based products for medical and pharmaceutical applications, including opthamology, intensive care, enteral feeding, drug infusion and delivery, cardiosurgery, orthopedics, fluid handling and neuromonitoring.